Hyundai Bioland Co., Ltd.
The clinical study aims to assess the long-term safety and efficacy of the interventional medical device. The clinical study will enrol up to 50 patients aged 18 years and older, who meet specific inclusion and exclusion criteria designed to ensure patient safety and reliable data collection.
Guided Bone Regeneration
GBR membrane
NA
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 50 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | Evaluation of Resorption, Safety, and Efficacy of Absorbable Collagen Membrane in Preventing Significant Bone Loss Following GBR (Guided Bone Regeneration) Procedure. |
Actual Study Start Date : | 2024-12-16 |
Estimated Primary Completion Date : | 2026-05-16 |
Estimated Study Completion Date : | 2026-06-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
No Location Found